CoChat

Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition

François, Hélène, Placier, Sandrine, Flamant, Martin, Tharaux, Pierre-Louis, Chansel, Dominique, Dussaule, Jean-Claude, Chatziantoniou, Christos · 2004 · The FASEB Journal
Cited by 112

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Hypertension is frequently associated with the development of renal vascular and glomerular fibrosis. The purpose of the present study was to investigate whether epidermal growth factor receptor (EGFR) activation participates in the development of renal fibrosis and to test if blockade of EGFR activation would have therapeutic effects. Experiments were performed during nitric oxide (NO) deficiency‐induced hypertension in rats (L‐NAME model). After 4 weeks of L‐NAME treatment, animals developed hypertension associated to deterioration of renal structure and function. Over the same period, EGFR was activated twofold within glomeruli. This activation was accompanied by increased activity of the mitogen‐activated protein kinase (MAPK) p42/p44 pathway and exaggerated collagen I expression. Gefitinib, an EGFR‐tyrosine kinase inhibitor, given concomitantly with L‐NAME, normalized MAPK activation and collagen I expression and prevented the decline of renal function and the development of fibrosis. Since endothelin mediates the L‐NAME‐induced fibrogenesis, the endothelin‐EGFR interaction was tested in transgenic mice expressing luciferase under the control of collagen I‐α2 promoter: In renal cortex of these animals, the endothelin‐induced collagen I gene activity was inhibited by an EGFR‐phosphorylation inhibitor. These results provide the first evidence that EGFR activation plays an important role in the progression of renal vascular and glomerular fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.03-0702fje

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 112

Metadata

Authors
François, H., Placier, S., Flamant, M., Tharaux, P.-L., Chansel, D., Dussaule, J.-C., & Chatziantoniou, C.
Venue
The FASEB Journal
Publisher
Wiley
Published
2004-03-19
Volume
18
Issue
7
Pages
926-928
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2130804465
Cited by
112
References
1
FWCI
4.29
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition. https://app.cochat.ai/papers/10.1096/fj.03-0702fje
The paper
François, H., Placier, S., Flamant, M., Tharaux, P.-L., Chansel, D., Dussaule, J.-C., & Chatziantoniou, C. (2004). Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition. The FASEB Journal. https://doi.org/10.1096/fj.03-0702fje

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.